ACHIEVING SUSTAINED MINIMAL DISEASE ACTIVITY WITH METHOTREXATE IN EARLY INTERLEUKIN 23-DRIVEN EARLY PSORIATIC ARTHRITIS

Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis

Objectives Methotrexate (MTX) is currently the recommended first-line therapy for treating psoriatic arthritis (PsA), despite lacking clear evidence.No estimates of efficacy of MTX in usual care and no clear MTX responsive clinical or laboratory variables are currently available.This study describes the response to MTX monotherapy in newly diagnose

read more

Formally Validated of Novel Tolling Service With the ITS-G5

The arrival of the connected and/or autonomous cars offers countless opportunities for both the user and service provider.In this paper, we present a novel solution Sterilization Accessories for tolling transaction using ITS-G5 technology.Specifically, it investigates how to secure tolling transactions performed with the cooperative intelligent tra

read more


A multi-year analysis of Canadian Arctic historical weather data in support of solar and wind renewable energy deployment

This work explores the importance of renewable resource temporal distribution for solar and wind energy deployment in Arctic communities to meet building and ancillary loads.An analysis of ten years of historic weather data was performed for six locations in the Canadian Arctic to assess renewable Bumpers resource variation.Simulations of similar c

read more